To check-in, please enter your registration information.
Remember Me
23 hours ago Novartis to acquire Synnovation Therapeutics’s pan-mutant selective PI3Kα inhibitor program
3/18/2026ARPA-H Grants BioCurie Funds to Build Scalable Gene Therapy Manufacturing Platform
2/17/2026Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval
2/17/2026Delaware Doctors Work to Reverse Genetic Disease
4/30/2026Delaware's DNA 2026 Life Science Conference
Print Page